A total of five of the National Institutes of Health invite applications for their assay development and screening for discovery of probes or therapeutic agents (R01) funding opportunity. This supports research in discovery and development of novel, small molecules for their potential use in studying disease treatment, and to generate new insight into the biology of relevant diseases and processes that are not yet drug targets. Stages of discovery research covered include:
•assay development;
•primary screen implementation to identify initial hits;
•hit validation
Eligibility
- Higher Education Institutions
- Nonprofits Other Than Institutions of Higher Education
- For-Profit Organizations
- Governments
- Other
Click here for the full eligibility information.
Available Funding
Application budgets are not limited but need to reflect the actual needs of the proposed project, for a period of up to four years.
Useful Links
- Full details regarding this NIH opportunity
Deadlines
| CORIS Internal Deadline for Review | Please contact your Heloise Emdon |
| cuResearch Checklist Deadline | Prior to submission to sponsor |
| Submission to Sponsor | Earliest submission date is September 5, 2017; opportunity is recurring and has no due date |
Submitting Your Checklist Application
- Checklists must be submitted via cuResearch, through which Departmental and Associate Dean’s approval must be provided to complete the online application process.
- More information on cuResearch can be found here.
Internal Contacts
If you would like assistance with proposal development and/or a substantive review of your proposal, please contact Heloise Emdon.